Nethradhama collaborates with ZEISS India to launch Karnataka’s first specialised Myopia Clinic

0
259
Nethradhama collaborates with ZEISS India to launch Karnataka’s first specialised Myopia Clinic
Nethradhama collaborates with ZEISS India to launch Karnataka’s first specialised Myopia Clinic

Bengaluru: Nethradhama Super Speciality Eye Hospital, a pioneering institution in eye care, in association with ZEISS India, announced the launch of Karnataka’s first specialized Myopia Clinic, to address the rising epidemic of myopia among children in India. This clinic offers the cutting-edge Myopia Master® technology, for the comprehensive myopia management of children up to 15 years of age.

The launch of the Myopia Clinic at Nethradhama’s Centre of Excellence in Jayanagar, was graced by the esteemed presence of Dr. Arokia Raj, Principal and Director, Bangalore International Academy & Group of Institutions, Shri Sharath Lohitashwa, veteran Kannada actor and Mr. Rohan Paul, Business Head – India & Neighbouring Countries, Carl Zeiss India.

A research gate study based on the prediction model for 2050, reveals a steady rise in myopia among urban children aged 5 to 15, with rates climbing from around 4.5% in 1999 to 21.15% in 2019. Basis the upward trajectory, it can be established that the myopia prevalence is projected to reach 48.14% by 2050. Without any proactive measures or lifestyle modifications, the overall prevalence of myopia across all age groups is expected to grow by 10.53% in the next 30 years. The pattern reflects the current scenario in East Asia Pacific and highlights the alarming need to address the myopia crisis in India. 

Without any proactive measures or lifestyle modifications, the overall prevalence of myopia across all age groups is expected to grow by 10.53% in the next 30 years. The pattern reflects the current scenario in East Asia Pacific and highlights the alarming need to address the myopia crisis in India.

Commenting on the launch of the new clinic, Dr. Sri Ganesh, Chairman and Managing Director, Nethradhama Super Speciality Eye Hospital, Bangalore, said “We are happy to partner with ZEISS India and announce the launch of our specialized Myopia Clinic, which will effectively help in reducing the progression of the myopia epidemic in India. At Nethradhama, we believe in enabling our healthcare providers and our patients with latest technologies and innovations in ophthalmology. With Myopia Master® technology, we will strive to provide early detection and effective management of myopia in children.”

Dr. Suman Shree R, Director and CEO, Nethradhama Super Speciality Eye Hospital, Bangalore further adds, “Childhood myopia is a major public health problem in India and it is expected to increase exponentially in the coming years. Through specialised clinics and technologies like Myopia Master®, we urge parents to get their children’s eyes examined atleast once in a year. With partners like ZEISS India, we will continue to improve myopia management and early diagnosis of the disease.”

The Myopia Master® technology, is an all-in-one device for myopia measurements. It combines refraction, axial length, and keratometry, which are essential parameters for myopia management. The Myopia Master® performs fast, contactless measurements of key parameters related to myopia development, usually taking less than two minutes. The advanced technology allows for individualised treatment and counselling, ensuring that each child receives the most effective care. Additionally, after the assessment, an ophthalmologist will review each case and make decisions on an individual basis.

Mr. Rohan Paul, Business Head – India & Neighbouring Countries, Carl Zeiss India, said, “We are thrilled to support Nethradhama in establishing Karnataka’s first Myopia Clinic in a hospital. This partnership reflects our commitment to advancing eye care and addressing childhood myopia with our expertise and resources. With myopia on the rise, dedicated clinics using advanced technology are essential. They provide precise diagnostics and tailored treatments, ensuring early detection and better eye health for the young population.”